Catalent to help Novo Nordisk address production demands for Ozempic and Wegovy: GlobalData
The acquisition of Catalent by Novo Holdings expects to see three new manufacturing sites added to Novo Nordisk’s arsenal, to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Ozempic
US FDA approves Novo Nordisk’s Ozempic 2 mg to treat type-II diabetes
Ozempic demonstrated 2.1 per cent blood sugar reduction and also weight loss in adults with type-II diabetes with new 2 mg dose
Global diabetes therapeutic market has grown sixfold in last two decades: GlobalData
The market has been a lucrative space for drug developers, as the disease is highly prevalent and patient numbers are expected to…
T2D market will grow from a total of $48.1bn sales in 2019 to $91.9 bn in 2029
T2D market growth factors are increasing diagnosed prevalence of disease and the emergence of novel pipeline agents